Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$115.19 - $132.77 $4.31 Million - $4.97 Million
37,400 Added 296.83%
50,000 $6.02 Million
Q4 2023

Feb 14, 2024

SELL
$114.26 - $136.0 $2.87 Million - $3.42 Million
-25,133 Reduced 66.61%
12,600 $1.55 Million
Q3 2023

Nov 14, 2023

BUY
$122.0 - $145.31 $4.6 Million - $5.48 Million
37,733 New
37,733 $4.88 Million
Q4 2021

Feb 14, 2022

SELL
$119.87 - $145.67 $2.1 Million - $2.55 Million
-17,500 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$128.64 - $184.79 $2.25 Million - $3.23 Million
17,500 New
17,500 $2.28 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.